AbbVie, Genmab Need Further Follow Up on Trial for Follicular Lymphoma Treatment

 AbbVie and Genmab said Tuesday that a clinical trial for a bispecific antibody to treat a form of non-Hodgkin's lymphoma would need further follow up, even after it saw positive topline results.

https://www.marketwatch.com/story/abbvie-genmab-need-further-follow-up-on-trial-for-follicular-lymphoma-treatment-f5c67371